FOXD3 overexpression suppressed proliferation and enhanced starvation-induced apoptosis in U87MG cells. by Wei Du (88790)

Mean decrease in accuracy for candidate variables. by Maogui Hu (319021)

Triclabendazole decreases intracellular cAMP. by Yong Joo Lee (357685)

TIG3 decreases cell survival. by Tiffany M. Scharadin (345930)

“…<b>A</b> TIG3 expression decreases cell number. Values are mean ± SEM, n = 3. …”

Sphingomyelinase activity decreases in Alzheimer’s disease. by Alfred N. Fonteh (486638)

Time-dependent decreases in beclin-1 (A), Atg5 (B), and SIRT1 (C) protein expression in N2a cells exposed to exogenous Aβ1–42 (10μ μM). by Hye Rin Lee (616252)

AICD transgenic mice show decreased cell proliferation in the SGZ of hippocampus. by Kaushik Ghosal (244754)

“…<p>Representative images of BrdU immunostaining in the subgranular zone (SGZ) of the dentate gyrus performed on 1.5-mont-old (<b>A</b>) 3-month-old (<b>C</b>) and 12-month old (<b>D</b>) wild-type and FeCγ25 animals one day after the final BrdU injection (100 mg/kg). …”

CpG/c stimulated CLL B cells exhibit decreased survival and decreased activation of the Wnt pathway. by Albert Gutierrez Jr. (342562)

Tetrandrine decreases Mtb antigen presentation. by Elham Karamooz (2584474)

AHCC decreases survival of AML cells. by Kavin Fatehchand (4262467)

At lower concentrations, METH decreases LTP. by Jarod Swant (246454)

“…<p>At higher concentrations, METH increases baseline synaptic transmission and decreases LTP. (<b>A</b>) Summary plot of normalized fEPSP slope measurements recorded in the CA1 region of the hippocampus. …”

GCase activity is significantly decreased in the brain and liver of the homozygous <i>GBA1</i> D409V KI mouse model at 4, 8, and 12 months of age. by Nicole K. Polinski (10947787)

“…In whole brain homogenate (A,C) and liver homogenate (B,D), GCase activity is significantly decreased in the <i>GBA1</i> D409V KI homozygous (HOM) mice as compared to C57Bl/6 wild type (WT) mice (n = 7/group). …”

Brain and liver GCase activity are significantly decreased in heterozygous <i>GBA1</i> D409V KI mice, with varying differences in glucosphingolipid lipids in brain and liver. by Nicole K. Polinski (10947787)

“…(A-B) GCase levels as assessed by the CBE/4-MU method are significantly decreased in the het <i>GBA1</i> D409V KI mice at 5 months of age in both brain (A) and liver (B). …”

Preconditioning anti-VEGF antibody decreased IR-induced expression of NF-κB activation and nuclear translocation. by Chou-Chin Lan (2938674)

Decreased mutagen susceptibility of WNV replication complex mutants. by Greta A. Van Slyke (761322)

Decreasing infection with heterogeneity in host protection. by M. Gabriela M. Gomes (251416)

Phagocytosis is sharply decreased in CF macrophages. by Karin Simonin-Le Jeune (464354)

SAA decreases the expression of adipocyte markers. by Aurélie Faty (169741)

Pharmacological treatments decrease actin polymerization. by Romain Ferru-Clément (701878)

Foxa1 decreases FA uptake. by Marta Moya (188959)